GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » Change In Payables And Accrued Expense

Zahravi Pharmacutical Co (XTEH:DZAH1) Change In Payables And Accrued Expense : IRR0.00 Mil (TTM As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Zahravi Pharmacutical Co Change In Payables And Accrued Expense?

Zahravi Pharmacutical Co's Change In Payables And Accrued Expense for the quarter that ended in . 20 was IRR0.00 Mil. It means Zahravi Pharmacutical Co's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .

Zahravi Pharmacutical Co's Change In Payables And Accrued Expense for the fiscal year that ended in . 20 was IRR0.00 Mil. It means Zahravi Pharmacutical Co's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .


Zahravi Pharmacutical Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Zahravi Pharmacutical Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zahravi Pharmacutical Co Change In Payables And Accrued Expense Chart

Zahravi Pharmacutical Co Annual Data
Trend
Change In Payables And Accrued Expense

Zahravi Pharmacutical Co Semi-Annual Data
Change In Payables And Accrued Expense

Zahravi Pharmacutical Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in . 20 was IRR0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zahravi Pharmacutical Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Zahravi Pharmacutical Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Zahravi Pharmacutical Co (XTEH:DZAH1) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
18th km of Karaj Special Road, Darupakhsh Street, Darupakhsh Factories, Entrance No. 2, No. 23, Tehran, IRN
Zahravi Pharmacutical Co is engaged in the pharmaceutical sector. It produces various tablets, capsules, injections, and soft gel capsules. Some of its products are Cograft, Iminoral, Clexaparin, Roaccutane, and others.

Zahravi Pharmacutical Co (XTEH:DZAH1) Headlines

No Headlines